Krsnaa Diagnostics Share News - Latest Updates, Live News & More

Latest news about Krsnaa Diagnostics

Krsnaa Diagnostics Schedules Q3FY26 Earnings Conference Call for February 6, 2026 2 days ago

Krsnaa Diagnostics Limited has scheduled its Q3FY26 earnings conference call for February 6, 2026, at 12:30 PM IST to discuss results for the quarter and nine months ended December 31, 2025. The call will feature senior management including Chairman Rajendra Mutha and Managing Director Yash Mutha, organized by PhillipCapital India with multiple dial-in options for participants. The company will subsequently publish the transcript and audio recording on its investor website, maintaining transparency under SEBI regulatory requirements.

Krsnaa Diagnostics CFO Pawan Daga Resigns After Five Years of Service Jan 15, 2026

Krsnaa Diagnostics Board Approves ₹430 Cr NCD Issuance with 7-Year Tenure Dec 12, 2025

Krsnaa Diagnostics Reports 22% Profit Surge in Q2 FY26, Driven by Margin Expansion Nov 10, 2025

Krsnaa Diagnostics Aims for 20%+ Revenue Growth Through Expansion and AI Integration Nov 07, 2025

More news about Krsnaa Diagnostics

07Nov 25

Krsnaa Diagnostics Reports 10.5% Revenue Growth in Q2 FY2025-26

Krsnaa Diagnostics Limited has reported robust financial results for Q2 FY2025-26. Revenue from operations increased by 10.5% year-over-year to 2,059.91 million rupees. EBITDA grew by 19.9% to 592.39 million rupees, with the EBITDA margin expanding by 222 basis points to 28.74%. Net profit rose by 22.2% to 239.45 million rupees. As of September 30, 2025, the company's total assets stood at 15,066.91 million rupees, with total equity of 9,229.55 million rupees.

19Aug 25

Krsnaa Diagnostics Reports 13% Revenue Growth in Q1, Wins Major Rajasthan PPP Contract

Krsnaa Diagnostics achieved 13% YoY revenue growth to INR 1,930 million in Q1, with EBITDA at INR 524 million and PAT at INR 205 million. The company served 5 million patients, processed 16 million tests, and expanded retail touchpoints from 362 to 2,414. Krsnaa won a significant PPP contract in Rajasthan, involving 42 mother labs, 135 satellite labs, and over 1,300 collection centers, expected to generate INR 300-350 crores in annualized revenue. The company plans to invest INR 200-250 crores in this project, with implementation expected within 6-9 months.

13Aug 25

Krsnaa Diagnostics Reports Robust Q1 FY2026 Results with 18.26% Revenue Growth and 37.94% Profit Surge

Krsnaa Diagnostics announced robust Q1 FY2026 results, with standalone revenue up 18.26% YoY to ₹307.82 crores and profit after tax surging 37.94% YoY to ₹41.62 crores. Consolidated revenue increased 18.26% YoY to ₹309.26 crores. The company approved results on August 11, published them on August 13, and held an earnings call on August 12. A physical investor meeting with Systematix Group is scheduled for August 21 in Mumbai.

11Aug 25

Krsnaa Diagnostics Unveils Ambitious Expansion Plan, Reports Strong Q1 Performance

Krsnaa Diagnostics plans to establish over 700 retail centers and 5,000+ collection points by FY27. Q1 financial results show 13% revenue growth to ₹1,929.78 million, 19% EBITDA increase to ₹524.00 million, and 15% PAT growth to ₹205.20 million. The company served about 5 million patients and performed 16 million tests in Q1. Retail revenue surged to ₹118 million, up from ₹15 million in the previous year's Q1. The company aims to become one of Asia's largest radiology players and expand its pathology network significantly.

11Aug 25

Krsnaa Diagnostics Reports Robust Q1 Performance with 13% Revenue Growth

Krsnaa Diagnostics announced robust Q1 financial results, with consolidated revenue increasing 13% to 1,930.00 million rupees. EBITDA rose 19% to 524.00 million rupees, and net profit grew 15% to 205.00 million rupees. The company served 5 million patients and performed 16 million tests. Retail expansion led to a significant increase in touchpoints from 362 to 2,414, with retail revenue surging from 15.00 million to 118.00 million rupees. Krsnaa plans to expand to over 200 CT/MRI centers and has secured a major project in Rajasthan under the National Health Mission.

05Aug 25

Krsnaa Diagnostics Secures Major Contract with National Health Mission in Rajasthan

Krsnaa Diagnostics, in consortium with Telecommunications Consultants India Ltd. (TCIL), has signed an agreement with the National Health Mission, Rajasthan to provide laboratory services under the Free Diagnostics Initiative. The partnership involves implementing a HUB and SPOKE model for diagnostic services across the state. While the contract size is currently unestimated, this new project is expected to expand Krsnaa Diagnostics' presence in Rajasthan's public health sector.

05Aug 25

Krsnaa Diagnostics Secures Contract for Free Diagnostic Services in Rajasthan

Krsnaa Diagnostics and Telecommunications Consultants India Ltd. (TCIL) have signed an agreement with the National Health Mission, Rajasthan to provide laboratory services under the Free Diagnostics Initiative. The contract involves implementing a HUB and SPOKE Model for laboratory services across Rajasthan, aiming to enhance accessibility to diagnostic services, especially in remote areas. The exact contract size is undisclosed due to the project's novel nature. This agreement represents a significant opportunity for Krsnaa Diagnostics to expand its presence in Rajasthan's public health sector.

07Jul 25

Krsnaa Diagnostics Secures License to Provide Free Lab Services in Rajasthan

Krsnaa Diagnostics has been awarded a new license by the Rajasthan government to provide free laboratory services across the state. This development follows a recent court ruling and aligns with the company's mission to improve healthcare accessibility. The license allows Krsnaa Diagnostics to operate and offer a range of diagnostic services at no cost to patients throughout Rajasthan, potentially benefiting residents who previously faced financial barriers to essential tests. This strategic expansion strengthens Krsnaa's position in the public health sector and demonstrates its commitment to partnering with state authorities.

12May 25

Krsnaa Diagnostics Reports Strong Q4 Results with Improved EBITDA, Net Profit, and Recommends Dividend

Krsnaa Diagnostics announced robust Q4 financial results, with revenue increasing 12% year-over-year to 1.86 billion rupees. EBITDA grew 21.3% to 530 million rupees, with an improved margin of 28.48%. Net profit rose 10.7% to 207 million rupees. The company's annual revenue increased by 25.65% to 636.40 crore rupees. A dividend of 2.75 rupees per share has been recommended.